SEC
SlamSEC
Search
Browse
Earnings
NEXGEL, INC. — SlamSEC
NEXGEL, INC.
Nasdaq:
NXGL
Nasdaq:
NXGLW
Surgical & Medical Instruments & Apparatus
·
LANGHORNE, PA
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Summary Financials
CEO
Levy Adam R.
Revenue
$4.1M
+99.7% YoY
FY 2024
Adj. EBITDA
-$3.3M
-79.5% margin
FY 2024
Net Income
-$3.2M
-77.2% margin
FY 2024
EPS (Diluted)
-$0.56
FY 2024
Stock Price
$0.83
-13.0%
2026-03-13
52W Range
$0.70 – $3.25
P/E Ratio
-1.5x
Market Cap
$6.8M
Cash
$32,000
FY 2021
Total Debt
$930,000
FY 2024
Net Debt
$898,000
FY 2024
Enterprise Value
$7.7M
Debt / EBITDA
-0.3x
FY 2024
EV / EBITDA
-2.4x
Employees
—